Westpac Banking Corp’s Core Laboratories CLB Stock Holding History

Westpac Banking Corp’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,910	Closed	-$287K	–	720
2017 Q3	$287K	Hold	2,910	–	–	0.01%	760
2017 Q2	$295K	Hold	2,910	–	–	0.01%	805
2017 Q1	$336K	Buy	+2,910	New	+$338K	﹤0.01%	875
2016 Q3	–	Sell	-2,122	Closed	-$263K	–	822
2016 Q2	$263K	Buy	2,122 +511	+32%	+$61.7K	﹤0.01%	815
2016 Q1	$181K	Buy	+1,611	New	+$167K	﹤0.01%	822
2015 Q2	–	Sell	-700	Closed	-$95.7K	–	893
2015 Q1	$95.7K	Sell	700 -2,362	-77%	-$252K	﹤0.01%	919
2014 Q4	$368K	Hold	3,062	–	–	﹤0.01%	809
2014 Q3	$448K	Hold	3,062	–	–	﹤0.01%	770
2014 Q2	$512K	Buy	3,062 +862	+39%	+$153K	﹤0.01%	745
2014 Q1	$437K	Sell	2,200 -413	-16%	-$78K	﹤0.01%	744
2013 Q4	$499K	Hold	2,613	–	–	0.01%	748
2013 Q3	$442K	Sell	2,613 -52	-2%	-$8.07K	0.01%	757
2013 Q2	$391K	Buy	+2,665	New	+$378K	0.01%	782

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Westpac Banking Corp's CLB Position: Q4 2017 in Review

Westpac Banking Corp sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 2,910 shares — an estimated $287K sold.

Westpac Banking Corp first reported a position in CLB in Q2 2013 and held it in 13 quarters. The position peaked at $512K in Q2 2014. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

Westpac Banking Corp reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
Westpac Banking Corp sold 2,910 Core Laboratories shares in Q4 2017, an estimated $287K.
Westpac Banking Corp first reported a position in Core Laboratories in Q2 2013 and held it in 13 quarters.
Westpac Banking Corp's Core Laboratories position peaked at $512K in Q2 2014.
356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Westpac Banking Corp's 13F filing for Q4 2017, filed 18 Jan 2018.